Patent Prosecutors Alarmed By Inequitable Conduct Ruling
By Ryan Davis (August 2, 2017, 10:27 PM EDT) -- A Federal Circuit decision finding a Regeneron Pharmaceuticals Inc. patent unenforceable due to inequitable conduct based partly on the behavior of litigators in an infringement case has alarmed attorneys who seek patents, who said it is unfair to tarnish the reputation of patent prosecutors using the actions of others.
Inequitable conduct is found when a patent applicant breaches its duty of candor to the U.S. Patent and Trademark Office during the application process, and it has been called the "atomic bomb" of patent law because it renders the patent entirely unenforceable. The Federal Circuit on July 27 upheld a lower court...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!